APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Against Infectious Coryza for Poultry

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vaccine Against Infectious Coryza for Poultry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025189 pages

Choose your research edition.

Industry ResearchVaccine Against Infectious Coryza for Poultry Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Against Infectious Coryza for Poultry Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Vaccine Against Infectious Coryza for Poultry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Against Infectious Coryza for Poultry Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine Against Infectious Coryza for Poultry Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Vaccine Against Infectious Coryza for Poultry market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vaccine Against Infectious Coryza for Poultry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccine Against Infectious Coryza for Poultry include HIPRA, MSD Animal Health, Qilu Animal Health, Ringpu, Shandong Huahong Biological, Shandong Lvdu Bio-Sciences, Wohua Biotech and Jilin Zhengye Biological Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vaccine Against Infectious Coryza for Poultry market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine Against Infectious Coryza for Poultry and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine Against Infectious Coryza for Poultry sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccine Against Infectious Coryza for Poultry market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccine Against Infectious Coryza for Poultry Segment by Company

HIPRA

MSD Animal Health

Qilu Animal Health

Ringpu

Shandong Huahong Biological

Shandong Lvdu Bio-Sciences

Wohua Biotech

Jilin Zhengye Biological Products

Vaccine Against Infectious Coryza for Poultry Segment by Type

Serotype A

Serotype A + Serotype B

Serotype A + Serotype B + Serotype C

Vaccine Against Infectious Coryza for Poultry Segment by Application

Government Tender

Market Sales

Vaccine Against Infectious Coryza for Poultry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Against Infectious Coryza for Poultry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Against Infectious Coryza for Poultry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Against Infectious Coryza for Poultry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccine Against Infectious Coryza for Poultry market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccine Against Infectious Coryza for Poultry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vaccine Against Infectious Coryza for Poultry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vaccine Against Infectious Coryza for Poultry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vaccine Against Infectious Coryza for Poultry Industry Trends Table 2. Vaccine Against Infectious Coryza for Poultry Industry Drivers Table 3. Vaccine Against Infectious Coryza for Poultry Industry Opportunities and Challenges Table 4. Vaccine Against Infectious Coryza for Poultry Industry Restraints Table 5. Global Vaccine Against Infectious Coryza for Poultry Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vaccine Against Infectious Coryza for Poultry Sales by Manufacturers (k doses) & (2021-2026) Table 8. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Manufacturers Table 9. Global Vaccine Against Infectious Coryza for Poultry Average Sales Price (US$/k dose) of Manufacturers (2021-2026) Table 10. Global Vaccine Against Infectious Coryza for Poultry Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vaccine Against Infectious Coryza for Poultry Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vaccine Against Infectious Coryza for Poultry Manufacturers, Product Type & Application Table 13. Global Vaccine Against Infectious Coryza for Poultry Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vaccine Against Infectious Coryza for Poultry by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Serotype A Table 17. Major Manufacturers of Serotype A + Serotype B Table 18. Major Manufacturers of Serotype A + Serotype B + Serotype C Table 19. Global Vaccine Against Infectious Coryza for Poultry Sales by Type 2021 VS 2025 VS 2032 (k doses) Table 20. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2026) & (k doses) Table 21. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2027-2032) & (k doses) Table 22. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Type (2021-2026) Table 23. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Type (2027-2032) Table 24. Global Vaccine Against Infectious Coryza for Poultry Revenue by Type 2021 VS 2025 VS 2032 (k doses) Table 25. Global Vaccine Against Infectious Coryza for Poultry Revenue by Type (2021-2026) & (k doses) Table 26. Global Vaccine Against Infectious Coryza for Poultry Revenue by Type (2027-2032) & (k doses) Table 27. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Type (2021-2026) Table 28. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Government Tender Table 30. Major Manufacturers of Market Sales Table 31. Global Vaccine Against Infectious Coryza for Poultry Sales by Application 2021 VS 2025 VS 2032 (k doses) Table 32. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2026) & (k doses) Table 33. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2027-2032) & (k doses) Table 34. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Application (2021-2026) Table 35. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Application (2027-2032) Table 36. Global Vaccine Against Infectious Coryza for Poultry Revenue by Application 2021 VS 2025 VS 2032 (k doses) Table 37. Global Vaccine Against Infectious Coryza for Poultry Revenue by Application (2021-2026) & (k doses) Table 38. Global Vaccine Against Infectious Coryza for Poultry Revenue by Application (2027-2032) & (k doses) Table 39. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Application (2021-2026) Table 40. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Application (2027-2032) Table 41. Global Vaccine Against Infectious Coryza for Poultry Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 42. Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2021-2026) & (k doses) Table 43. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Region (2021-2026) Table 44. Global Vaccine Against Infectious Coryza for Poultry Sales Forecasted by Region (2027-2032) & (k doses) Table 45. Global Vaccine Against Infectious Coryza for Poultry Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 47. North America Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 48. North America Vaccine Against Infectious Coryza for Poultry Sales by Country (2027-2032) & (k doses) Table 49. Europe Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 50. Europe Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 51. Europe Vaccine Against Infectious Coryza for Poultry Sales by Country (2027-2032) & (k doses) Table 52. Asia Pacific Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 53. Asia Pacific Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 54. Asia Pacific Vaccine Against Infectious Coryza for Poultry Sales by Country (2027-2032) & (k doses) Table 55. South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 56. South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2026) & (k doses) Table 57. South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Country (2027-2032) & (k doses) Table 58. Global Vaccine Against Infectious Coryza for Poultry Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Vaccine Against Infectious Coryza for Poultry Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Vaccine Against Infectious Coryza for Poultry Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Region (2021-2026) Table 62. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Region (2027-2032) Table 63. HIPRA Company Information Table 64. HIPRA Business Overview Table 65. HIPRA Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. HIPRA Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 67. HIPRA Recent Development Table 68. MSD Animal Health Company Information Table 69. MSD Animal Health Business Overview Table 70. MSD Animal Health Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. MSD Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 72. MSD Animal Health Recent Development Table 73. Qilu Animal Health Company Information Table 74. Qilu Animal Health Business Overview Table 75. Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 77. Qilu Animal Health Recent Development Table 78. Ringpu Company Information Table 79. Ringpu Business Overview Table 80. Ringpu Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ringpu Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 82. Ringpu Recent Development Table 83. Shandong Huahong Biological Company Information Table 84. Shandong Huahong Biological Business Overview Table 85. Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 87. Shandong Huahong Biological Recent Development Table 88. Shandong Lvdu Bio-Sciences Company Information Table 89. Shandong Lvdu Bio-Sciences Business Overview Table 90. Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 92. Shandong Lvdu Bio-Sciences Recent Development Table 93. Wohua Biotech Company Information Table 94. Wohua Biotech Business Overview Table 95. Wohua Biotech Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Wohua Biotech Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 97. Wohua Biotech Recent Development Table 98. Jilin Zhengye Biological Products Company Information Table 99. Jilin Zhengye Biological Products Business Overview Table 100. Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Sales (k doses), Price (US$/k dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Product Portfolio Table 102. Jilin Zhengye Biological Products Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Vaccine Against Infectious Coryza for Poultry Distributors List Table 106. Vaccine Against Infectious Coryza for Poultry Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Vaccine Against Infectious Coryza for Poultry Product Image Figure 2. Global Vaccine Against Infectious Coryza for Poultry Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Against Infectious Coryza for Poultry Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccine Against Infectious Coryza for Poultry Sales (2021-2032) & (k doses) Figure 5. Global Vaccine Against Infectious Coryza for Poultry Average Price (US$/k dose) & (2021-2032) Figure 6. Global Top 5 and 10 Vaccine Against Infectious Coryza for Poultry Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Serotype A Image Figure 9. Serotype A + Serotype B Image Figure 10. Serotype A + Serotype B + Serotype C Image Figure 11. Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2021 VS 2025 VS 2032) & (k doses) Figure 12. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Type (2021-2032) Figure 14. Global Vaccine Against Infectious Coryza for Poultry Revenue by Type (2021 VS 2025 VS 2032) & (k doses) Figure 15. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Type (2021-2032) Figure 17. Government Tender Image Figure 18. Market Sales Image Figure 19. Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2021 VS 2025 VS 2032) & (k doses) Figure 20. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Application (2021-2032) Figure 22. Global Vaccine Against Infectious Coryza for Poultry Revenue by Application (2021 VS 2025 VS 2032) & (k doses) Figure 23. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Application (2021-2032) Figure 25. North America Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 26. North America Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2032) Figure 27. U.S. Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 28. Canada Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 29. Mexico Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 30. Europe Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 31. Europe Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2032) Figure 32. Germany Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 33. France Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 34. U.K. Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 35. Italy Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 36. Netherlands Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 37. Asia Pacific Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 38. Asia Pacific Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2032) Figure 39. China Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 40. Japan Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 41. South Korea Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 42. Southeast Asia Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 43. India Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 44. Australia Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 45. South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 46. South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Market Share by Country (2021-2032) Figure 47. Brazil Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 48. South Africa Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 49. Saudi Arabia Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 50. Turkey Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 51. Argentina Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 52. UAE Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 53. Egypt Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 54. Chile Vaccine Against Infectious Coryza for Poultry Sales and Growth Rate (2021-2032) & (k doses) Figure 55. Global Vaccine Against Infectious Coryza for Poultry Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032) & (US$ Million) Figure 58. North America Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032) & (US$ Million) Figure 60. Europe Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Vaccine Against Infectious Coryza for Poultry Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Vaccine Against Infectious Coryza for Poultry Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Serotype A
  • Serotype A + Serotype B
  • Serotype A + Serotype B + Serotype C
Applications
  • Government Tender
  • Market Sales
Companies covered
  • HIPRA
  • MSD Animal Health
  • Qilu Animal Health
  • Ringpu
  • Shandong Huahong Biological
  • Shandong Lvdu Bio-Sciences
  • Wohua Biotech
  • Jilin Zhengye Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vaccine Against Infectious Coryza for Poultry Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vaccine Against Infectious Coryza for Poultry Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vaccine Against Infectious Coryza for Poultry Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vaccine Against Infectious Coryza for Poultry Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vaccine Against Infectious Coryza for Poultry Market Dynamics
  1. 2.1 Vaccine Against Infectious Coryza for Poultry Industry Trends
  2. 2.2 Vaccine Against Infectious Coryza for Poultry Industry Drivers
  3. 2.3 Vaccine Against Infectious Coryza for Poultry Industry Opportunities and Challenges
  4. 2.4 Vaccine Against Infectious Coryza for Poultry Industry Restraints
3 Vaccine Against Infectious Coryza for Poultry Market by Manufacturers
  1. 3.1 Global Vaccine Against Infectious Coryza for Poultry Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vaccine Against Infectious Coryza for Poultry Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vaccine Against Infectious Coryza for Poultry Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccine Against Infectious Coryza for Poultry Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vaccine Against Infectious Coryza for Poultry Manufacturers, Product Type & Application
  7. 3.7 Global Vaccine Against Infectious Coryza for Poultry Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccine Against Infectious Coryza for Poultry Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccine Against Infectious Coryza for Poultry Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccine Against Infectious Coryza for Poultry Tier 1, Tier 2, and Tier 3
4 Vaccine Against Infectious Coryza for Poultry Market by Type
  1. 4.1 Vaccine Against Infectious Coryza for Poultry Type Introduction
  2. 4.1.1 Serotype A
  3. 4.1.2 Serotype A + Serotype B
  4. 4.1.3 Serotype A + Serotype B + Serotype C
  5. 4.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Type
  6. 4.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Type (2021-2032)
  8. 4.2.3 Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Type (2021-2032)
  9. 4.3 Global Vaccine Against Infectious Coryza for Poultry Revenue by Type
  10. 4.3.1 Global Vaccine Against Infectious Coryza for Poultry Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Vaccine Against Infectious Coryza for Poultry Revenue by Type (2021-2032)
  12. 4.3.3 Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Type (2021-2032)
5 Vaccine Against Infectious Coryza for Poultry Market by Application
  1. 5.1 Vaccine Against Infectious Coryza for Poultry Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Application
  5. 5.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Application (2021-2032)
  7. 5.2.3 Global Vaccine Against Infectious Coryza for Poultry Sales Market Share by Application (2021-2032)
  8. 5.3 Global Vaccine Against Infectious Coryza for Poultry Revenue by Application
  9. 5.3.1 Global Vaccine Against Infectious Coryza for Poultry Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Vaccine Against Infectious Coryza for Poultry Revenue by Application (2021-2032)
  11. 5.3.3 Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Application (2021-2032)
6 Global Vaccine Against Infectious Coryza for Poultry Sales by Region
  1. 6.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2021-2032)
  3. 6.2.1 Global Vaccine Against Infectious Coryza for Poultry Sales by Region (2021-2026)
  4. 6.2.2 Global Vaccine Against Infectious Coryza for Poultry Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vaccine Against Infectious Coryza for Poultry Revenue by Region
  1. 7.1 Global Vaccine Against Infectious Coryza for Poultry Revenue by Region
  2. 7.1.1 Global Vaccine Against Infectious Coryza for Poultry Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vaccine Against Infectious Coryza for Poultry Revenue by Region (2021-2026)
  4. 7.1.3 Global Vaccine Against Infectious Coryza for Poultry Revenue by Region (2027-2032)
  5. 7.1.4 Global Vaccine Against Infectious Coryza for Poultry Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032)
  8. 7.2.2 North America Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032)
  11. 7.3.2 Europe Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vaccine Against Infectious Coryza for Poultry Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 HIPRA
  2. 8.1.1 HIPRA Company Information
  3. 8.1.2 HIPRA Business Overview
  4. 8.1.3 HIPRA Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 HIPRA Vaccine Against Infectious Coryza for Poultry Product Portfolio
  6. 8.1.5 HIPRA Recent Developments
  7. 8.2 MSD Animal Health
  8. 8.2.1 MSD Animal Health Company Information
  9. 8.2.2 MSD Animal Health Business Overview
  10. 8.2.3 MSD Animal Health Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MSD Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio
  12. 8.2.5 MSD Animal Health Recent Developments
  13. 8.3 Qilu Animal Health
  14. 8.3.1 Qilu Animal Health Company Information
  15. 8.3.2 Qilu Animal Health Business Overview
  16. 8.3.3 Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Animal Health Vaccine Against Infectious Coryza for Poultry Product Portfolio
  18. 8.3.5 Qilu Animal Health Recent Developments
  19. 8.4 Ringpu
  20. 8.4.1 Ringpu Company Information
  21. 8.4.2 Ringpu Business Overview
  22. 8.4.3 Ringpu Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ringpu Vaccine Against Infectious Coryza for Poultry Product Portfolio
  24. 8.4.5 Ringpu Recent Developments
  25. 8.5 Shandong Huahong Biological
  26. 8.5.1 Shandong Huahong Biological Company Information
  27. 8.5.2 Shandong Huahong Biological Business Overview
  28. 8.5.3 Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shandong Huahong Biological Vaccine Against Infectious Coryza for Poultry Product Portfolio
  30. 8.5.5 Shandong Huahong Biological Recent Developments
  31. 8.6 Shandong Lvdu Bio-Sciences
  32. 8.6.1 Shandong Lvdu Bio-Sciences Company Information
  33. 8.6.2 Shandong Lvdu Bio-Sciences Business Overview
  34. 8.6.3 Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Lvdu Bio-Sciences Vaccine Against Infectious Coryza for Poultry Product Portfolio
  36. 8.6.5 Shandong Lvdu Bio-Sciences Recent Developments
  37. 8.7 Wohua Biotech
  38. 8.7.1 Wohua Biotech Company Information
  39. 8.7.2 Wohua Biotech Business Overview
  40. 8.7.3 Wohua Biotech Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wohua Biotech Vaccine Against Infectious Coryza for Poultry Product Portfolio
  42. 8.7.5 Wohua Biotech Recent Developments
  43. 8.8 Jilin Zhengye Biological Products
  44. 8.8.1 Jilin Zhengye Biological Products Company Information
  45. 8.8.2 Jilin Zhengye Biological Products Business Overview
  46. 8.8.3 Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jilin Zhengye Biological Products Vaccine Against Infectious Coryza for Poultry Product Portfolio
  48. 8.8.5 Jilin Zhengye Biological Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vaccine Against Infectious Coryza for Poultry Value Chain Analysis
  2. 9.1.1 Vaccine Against Infectious Coryza for Poultry Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vaccine Against Infectious Coryza for Poultry Production Mode & Process
  6. 9.2 Vaccine Against Infectious Coryza for Poultry Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vaccine Against Infectious Coryza for Poultry Distributors
  9. 9.2.3 Vaccine Against Infectious Coryza for Poultry Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst